Authors
Loading...
Research demonstrates HuR's involvement in immune evasion and KRAS signaling in pancreatic ductal adenocarcinoma, suggesting new therapeutic strategies.
Guo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: